✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic TinnitusCbdAudiologySymptom ManagementEvidence Gaps Why This MattersTinnitus affects 10-15% of adults with limited FDA-approved treatments,...
Autistic Adults Report Symptom Relief After Cannabis Use, But Study Cannot Confirm Cause
Overall, symptom severity ratings were reduced by 73.09% from before to after cannabis use. More severe symptoms were associated with greater reductions in severity ratings after use. Higher doses predicted greater reductions in severity of Repetitive Behaviors, Mental Control, and Negative Affect.
‘Medical cannabis has cured my severe social anxiety and PTSD’ says Milton Keynes artist
✦ New CED Clinical Relevance #76Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic PtsdAnxietyPatient TestimonialsMental HealthTreatment Expectations Why This MattersPatient testimonials claiming cannabis 'cured' anxiety and PTSD...
World’s largest cart and battery!
When your patient asks if there's a higher-capacity option, remind them that bigger hardware doesn't necessarily mean better pharmacokinetics. The real question is whether they're treating symptoms or just collecting peripherals. Via...
The Hemp Industry Gears Up to Fight for Its Continued Existence – Roundtable
✦ New CED Clinical Relevance #45 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyHempCBDIndustry Why This Matters Clinicians should understand that regulatory uncertainty around hemp-derived cannabinoids could disrupt...
Judge rules to temporarily block Texas’ smokeable hemp ban – KRGV
✦ New CED Clinical Relevance #45 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyHempTHC Why This Matters This ruling creates immediate uncertainty about which cannabis products are legally...
Salus at Drexel University to host continuing education event titled ‘Medical Marijuana
✦ New CED Clinical Relevance #72 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchEducationMedical CannabisNeurology Why This Matters Clinicians increasingly encounter patients using or asking about cannabis for...
How Much Terpene Spray Should You Use? – Terps USA® – YouTube
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic TerpenesDosingPatient EducationClinical GuidanceSafety Why This MattersTerpene dosing guidance remains largely empirical rather than evidence-based,...
Amyotrophic lateral sclerosis (ALS) – Center for Medical Cannabis – Utah.gov
✦ New CED Clinical Relevance #76Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic AlsNeurodegenerative DiseaseState GuidelinesPalliative CareSymptom Management Why This MattersUtah's evidence-based guidelines for ALS represent state-sanctioned...
Mapping the Gaps: What We Know—and Don’t Know—About Cannabis for Symptom Management in HIV and Cancer
There are limited metrics on the perceived effectiveness and safety of cannabis use for symptom management and its dosing/mode of delivery for reducing symptoms.